Legend from Five-Year Cervical (Pre)Cancer Risk of Women Screened by HPV and Cytology Testing

Autor: Chris J.L.M. Meijer, Peter J.F. Snijders, Johannes Berkhof, Dorien Rijkaart, Birgit I. Witte, Sander Van Den Haselkamp, Folkert J. Van Kemenade, Nicole J. Polman, Margot H. Uijterwaal

Legend: CIN=cervical intraepithelial neoplasia (grade 3 or higher); HPV=human papillomavirus; BMD=borderline/mild dyskaryosis.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acbb8f5e39a7a218f09d820d6e01c6ce
https://doi.org/10.1158/1940-6207.22524248.v1

Five-Year Cervical (Pre)Cancer Risk of Women Screened by HPV and Cytology Testing

Autor: Sander Van Den Haselkamp, Chris J.L.M. Meijer, D.C. Rijkaart, Birgit I. Witte, Peter J.F. Snijders, Margot H. Uijterwaal, Folkert J. van Kemenade, Johannes Berkhof, Nicole J. Polman

Publikováno v: Cancer Prevention Research, 8(6), 502-508. American Association for Cancer Research Inc.
Uijterwaal, M H, Polman, N J, van Kemenade, F J, Van den Haselkamp, S, Witte, B I, Rijkaart, D C, Berkhof, J, Snijders, P J F & Meijer, C J L M 2015, ' Five-Year Cervical (Pre)Cancer Risk of Women Screened by HPV and Cytology Testing ', Cancer Prevention Research, vol. 8, no. 6, pp. 502-508 . https://doi.org/10.1158/1940-6207.CAPR-14-0409

Primary human papillomavirus (HPV)–based cervical screening will be introduced in the Netherlands in 2016. We assessed the 5-year cervical (pre)cancer risk of women with different combinations of HPV and cytology test results. Special attention was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35d8c74bf7c0d66276e47884e9306774
https://doi.org/10.1158/1940-6207.capr-14-0409